ALUMIS INC
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
ALMS$6.40-2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · March 31, · December 31, | ||||||
| (in thousands, except share and per share amounts) · · 2025 · · 2024 | ||||||
| Assets · · | ||||||
| Current assets: · · | ||||||
| Cash and cash equivalents | | $128,543 | | $169,526 | ||
| Marketable securities | | 80,206 | | 118,737 | ||
| Research and development prepaid expenses | | 12,863 | | 13,424 | ||
| Other prepaid expenses and current assets | | 3,918 | | 4,501 | ||
| Total current assets | | 225,530 | | 306,188 | ||
| Restricted cash, non-current | | 1,162 | | 1,106 | ||
| Property and equipment, net | | 20,328 | | 20,968 | ||
| Operating lease right-of-use assets, net | | 14,233 | | 12,723 | ||
| Other long-term assets | | 45 | | 7 | ||
| Total assets | | $261,298 | | $340,992 | ||
| Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity | | | ||||
| Current liabilities: | | | ||||
| Accounts payable | | $7,473 | | $9,624 | ||
| Research and development accrued expenses | | 34,699 | | 29,149 | ||
| Other accrued expenses and current liabilities | | 15,733 | | 10,580 | ||
| Operating lease liabilities, current | | 2,545 | | 1,557 | ||
| Total current liabilities | | 60,450 | | 50,910 | ||
| Deferred revenue, non-current | | | 2,611 | | | — |
| Operating lease liabilities, non-current | | 29,335 | | 29,165 | ||
| Share repurchase liability | | 588 | | 813 | ||
| Total liabilities | | 92,984 | | 80,888 | ||
| Commitments and contingencies (Note 8) | | | ||||
| Stockholders’ equity: | | | | |||
| Preferred stock, $0.0001 par value; 50,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2025 and December 31, 2024 | | | — | | | — |
| Common stock, voting, $0.0001 par value; 492,815,092 voting shares authorized as of March 31, 2025 and December 31, 2024; 47,222,419 voting shares issued and outstanding as of March 31, 2025 and December 31, 2024 | | 4 | | 4 | ||
| Common stock, non-voting, $0.0001 par value; 7,184,908 non-voting shares authorized as of March 31, 2025 and December 31, 2024; 7,184,908 non-voting shares issued and outstanding as of March 31, 2025 and December 31, 2024 | | | 1 | | | 1 |
| Additional paid-in capital | | 925,831 | | 918,610 | ||
| Accumulated other comprehensive income (loss) | | (8) | | 40 | ||
| Accumulated deficit | | (757,514) | | (658,551) | ||
| Total stockholders’ equity | | 168,314 | | 260,104 | ||
| Total liabilities, redeemable convertible preferred stock and stockholders’ equity | | $261,298 | | $340,992 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.